A rapid in vitro labeling index method for predicting response of human solid tumors to chemotherapy.
A rapid autoradiographic technique for measuring the [3H]thymidine-labeling index of human solid tumors has been adapted to assess the effect of anticancer drugs in vitro. The drugs tested were present unchanged or as metabolites in serum obtained from patients immediately post-treatment. In 15 patients, the drugs tested in vitro were also given in vivo. Tumor-labeling index fell significantly in 5 of 6 patients who were later found to have objective clinical response. Tumor-labeling index did not change significantly in 8 patients and rose significantly in 1 of 9 patients who lacked clinical response. If confirmed, this in vitro test may prove to be a useful method of predicting responsiveness of human solid cancers to chemotherapeutic agents.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001345:Autoradiography / Q000379:methods; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy / Q000378:metabolism; D004341:Drug Evaluation / Q000379:methods*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008545:Melanoma / Q000097:blood / Q000188:drug therapy / Q000378:metabolism; D009369:Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D013936:Thymidine / Q000378:metabolism
D000970:Antineoplastic Agents; D013936:Thymidine